GLG News by Users of Dermal Fillers (US)
Request a free trial
August 5, 2008
IT'S A SHAME!
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Skin care encompasses cosmetic procedures. But those cosmetic procedures should not take priority over the medical conditions - especially since dermatologists are uniquely qualified to treat them. I didn't go to medical school, a residency in medicine, and a fellowship in dermatology to...
August 1, 2008Will access to dermatology care suffer with increased cosmetic procedures ?
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it describes a growing trend among dermatologists to offer a higher level of "customer service" for their cash paying cosmetic patients. This has contributed in a small way to the long waits for non cosmetic dermatology patients to be able to see a dermatologist....
July 31, 2008
who's to blame?
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
As a solo dermatologist who has been in practice for 34 years, I think some dermatologist have been forced to consecrate on cosmetic issues of patients due to the low reimbursements of insurance companies. I chose a different path in 1985. I opted not to participate in managed care...
July 18, 2008Will prescription drug spending decreases affect dermatology?
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it describes a worrying trend for branded pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived...
July 7, 2008Protopic use can prevent relapse
Analysis of: Intermittent tacrolimus Ointment therapy Helps Prevent Relapse Of Stabilized Atpoic Dermatitis | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it confirms a commonly used method in clinical dermatology practice. Namely that of using Protopic for longer term maintenance to prevent flares, and to act as a topical steroid sparing agent. This has been done since the introduction of Protopic, and among dermatologists...
July 7, 2008New uses for old meds- benefit or drawback?
Analysis of: One drug, many uses. Good idea? | www.indystar.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it describes a growing concern that is not well known to the investment community or the public. Due to increased pressure from the generic companies, the FDA, and the public many companies are finding new uses for older medications. This is very true in dermatology...
July 2, 2008Evolence Approval- what effect will it have on the filler market
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...
June 30, 2008
Government Health Service - A Disgrace
Analysis of: Roche decision denies cancer drug to Britons | www.ft.com
Author: GLG Expert Contributor
Analysis of: Roche decision denies cancer drug to Britons | www.ft.com
Author: GLG Expert Contributor
The notion that a government agency can provide excellent health service is debunked by the tragedy of the United Kingdom's National Health Service's rejection of a chemotherapeutic agent for the treatment of breast cancer.
June 27, 2008Adolesecnt acne treatable
Analysis of: What Skin Care Routines and Treatments Are Effective for Adolescent Acne? | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that, for the most part , it describes a basic therapeutic regimen for adolescent acne patients. The only error is describing the inflamed lesions as "infections." Acne is predominantly an inflammatory condition, not an infectious one, though a bacteria is involved...
June 25, 2008Allergan's acquisition of Aczone- is this significant?
Analysis of: Allergan Aquisition of Aczone | agn360.client.shareholder.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that this acquisition is the first new product for Allergan's dermatology division in several years. This is also the first novel molecule in 5-7 years that has been released. The issues of having to get blood tests with this topical agent have been solved. The obvious paring...
Page : 1 2 3 4 5 6 7 8 9 Next1 to 10 of 82
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta
www.fda.gov
Healthways' Guidance Not So Healthy
www.forbes.com
Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise
www.nytimes.com
Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
jco.ascopubs.org
Hospital Death Rates Unveiled for First-Time Comparison
www.usatoday.com
Dangers of Methadone Usage
August 28, 2008
Its all about the spin
August 21, 2008
Byetta sale will reduce after FAD alert
August 19, 2008
PCI numbers will not drop after Courage
August 19, 2008
Bad News (but not new news) for stents.
August 19, 2008

